呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

2023 GINA 全球哮喘处理和预防策略（更新版）

2023-05-02 全球哮喘防治创议 GINA官网 发表于上海

哮喘

2023年，全球哮喘防治创议(GINA)更新发布了全球哮喘处理和预防策略，主要内容涉及哮喘的定义和诊断，哮喘的评估、治疗，儿童哮喘的管理、儿童哮喘的一级预防等。

中文标题：

2023 GINA 全球哮喘处理和预防策略（更新版）

英文标题：

2023 GINA Report, Global Strategy for Asthma Management and Prevention

发布机构：

全球哮喘防治创议

发布日期：

2023-05-02

简要介绍：

全球哮喘管理和预防战略 的 2023 年更新版根据 GINA 科学委员会国际专家小组对近期科学文献的审查，纳入了有关哮喘的新科学信息。这一关于世界上最常见的慢性肺部疾病之一的全面而实用的资源包含对科学文献的广泛引用，并构成了其他 GINA 文件和程序的基础。

相关资料下载：
2023 GINA 全球哮喘处理和预防策略（更新版）.pdf
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2170371, encodeId=6f1321e0371de, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e9c3250052, createdName=12ced227m27暂无昵称, createdTime=Wed Nov 22 23:41:54 CST 2023, time=2023-11-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145279, encodeId=1e0321452e99d, content=ZAN, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff865728217, createdName=ms7000001721425841, createdTime=Wed Jun 28 22:10:02 CST 2023, time=2023-06-28, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2143010, encodeId=39ea214301092, content=请问 能免费下载吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b8b70213, createdName=pandianzhu, createdTime=Thu Jun 15 22:45:49 CST 2023, time=2023-06-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2142114, encodeId=afb321421149b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5081450389, createdName=52996766, createdTime=Sat Jun 10 22:38:26 CST 2023, time=2023-06-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2138578, encodeId=072321385e84c, content=评论, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2df18574547, createdName=直播小助手18501777186, createdTime=Tue May 23 14:17:41 CST 2023, time=2023-05-23, status=1, ipAttribution=上海)]
    2023-11-22 12ced227m27暂无昵称 来自广东省

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2170371, encodeId=6f1321e0371de, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e9c3250052, createdName=12ced227m27暂无昵称, createdTime=Wed Nov 22 23:41:54 CST 2023, time=2023-11-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145279, encodeId=1e0321452e99d, content=ZAN, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff865728217, createdName=ms7000001721425841, createdTime=Wed Jun 28 22:10:02 CST 2023, time=2023-06-28, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2143010, encodeId=39ea214301092, content=请问 能免费下载吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b8b70213, createdName=pandianzhu, createdTime=Thu Jun 15 22:45:49 CST 2023, time=2023-06-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2142114, encodeId=afb321421149b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5081450389, createdName=52996766, createdTime=Sat Jun 10 22:38:26 CST 2023, time=2023-06-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2138578, encodeId=072321385e84c, content=评论, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2df18574547, createdName=直播小助手18501777186, createdTime=Tue May 23 14:17:41 CST 2023, time=2023-05-23, status=1, ipAttribution=上海)]
    2023-06-28 ms7000001721425841 来自内蒙古

    ZAN

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2170371, encodeId=6f1321e0371de, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e9c3250052, createdName=12ced227m27暂无昵称, createdTime=Wed Nov 22 23:41:54 CST 2023, time=2023-11-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145279, encodeId=1e0321452e99d, content=ZAN, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff865728217, createdName=ms7000001721425841, createdTime=Wed Jun 28 22:10:02 CST 2023, time=2023-06-28, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2143010, encodeId=39ea214301092, content=请问 能免费下载吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b8b70213, createdName=pandianzhu, createdTime=Thu Jun 15 22:45:49 CST 2023, time=2023-06-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2142114, encodeId=afb321421149b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5081450389, createdName=52996766, createdTime=Sat Jun 10 22:38:26 CST 2023, time=2023-06-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2138578, encodeId=072321385e84c, content=评论, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2df18574547, createdName=直播小助手18501777186, createdTime=Tue May 23 14:17:41 CST 2023, time=2023-05-23, status=1, ipAttribution=上海)]
    2023-06-15 pandianzhu 来自辽宁省

    请问 能免费下载吗？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2170371, encodeId=6f1321e0371de, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e9c3250052, createdName=12ced227m27暂无昵称, createdTime=Wed Nov 22 23:41:54 CST 2023, time=2023-11-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145279, encodeId=1e0321452e99d, content=ZAN, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff865728217, createdName=ms7000001721425841, createdTime=Wed Jun 28 22:10:02 CST 2023, time=2023-06-28, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2143010, encodeId=39ea214301092, content=请问 能免费下载吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b8b70213, createdName=pandianzhu, createdTime=Thu Jun 15 22:45:49 CST 2023, time=2023-06-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2142114, encodeId=afb321421149b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5081450389, createdName=52996766, createdTime=Sat Jun 10 22:38:26 CST 2023, time=2023-06-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2138578, encodeId=072321385e84c, content=评论, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2df18574547, createdName=直播小助手18501777186, createdTime=Tue May 23 14:17:41 CST 2023, time=2023-05-23, status=1, ipAttribution=上海)]
    2023-06-10 52996766 来自云南省

    好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2170371, encodeId=6f1321e0371de, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e9c3250052, createdName=12ced227m27暂无昵称, createdTime=Wed Nov 22 23:41:54 CST 2023, time=2023-11-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145279, encodeId=1e0321452e99d, content=ZAN, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff865728217, createdName=ms7000001721425841, createdTime=Wed Jun 28 22:10:02 CST 2023, time=2023-06-28, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=2143010, encodeId=39ea214301092, content=请问 能免费下载吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b8b70213, createdName=pandianzhu, createdTime=Thu Jun 15 22:45:49 CST 2023, time=2023-06-15, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2142114, encodeId=afb321421149b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5081450389, createdName=52996766, createdTime=Sat Jun 10 22:38:26 CST 2023, time=2023-06-10, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2138578, encodeId=072321385e84c, content=评论, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2df18574547, createdName=直播小助手18501777186, createdTime=Tue May 23 14:17:41 CST 2023, time=2023-05-23, status=1, ipAttribution=上海)]
    2023-05-23 直播小助手18501777186 来自上海

    评论

    0

相关指南

2023 NICE 技术鉴定指导意见：特泽鲁单抗用于治疗严重哮喘[TA880]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-04-20

2021 JSA指南：成人哮喘（概要）

日本变态反应学会(JSA,Japanese Society of Allergology) · 2023-03-21

2022 NICE 医疗技术创新简报：智能峰值流量监测哮喘【MIB282】

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2022-01-11

2022 GMMMG 哮喘管理计划 - 吸入器指南

（GMMMG ，greater manchester medicines management group） 大曼彻斯特药品管理组 · 2022-10-01

2022 GMMMG 哮喘指南

（GMMMG ，greater manchester medicines management group） 大曼彻斯特药品管理组 · 2022-04-01

2020 JSA临床实践指南：哮喘的治疗和管理（概要）

日本变态反应学会(JSA,Japanese Society of Allergology) · 2022-09-06

拓展阅读

清华大学彭敏Nature Immunology：开发哮喘新疗法，利用长效CAR T细胞靶向IL-5和阻断IL-4/IL-13信号

研究人员利用IL-5作为靶向领域，开发了一种可以消灭嗜酸性粒细胞的长寿命嵌合抗原受体（CAR）T细胞，这些细胞被称为5TIF细胞。

儿童重症哮喘治疗新趋势：HFNC的崛起与BPAP的坚守

本研究利用虚拟儿科系统数据库估计NRS的处方率，并根据最初应用的NRS设备描述患者的临床特征和住院结果。

哮喘患者的麻醉管理

围术期遭遇哮喘，如果处理不及时，可能导致严重后果。

J Asthma Allergy：中国学者揭示唾液胃蛋白酶浓度升高是过敏性鼻炎患儿患哮喘的风险因素

研究人员分析了唾液胃蛋白酶浓度（SPC）是否可作为过敏性鼻炎患儿发生哮喘和哮喘控制不良的风险因素。结果发现，SPC值可视为过敏性鼻炎患儿发生哮喘的危险因素。

Int Arch Allergy Immunol：华南地区哮喘和/或鼻炎患者中花粉过敏原成分的致敏差异分析

研究人员分析了导致过敏性哮喘和/或鼻炎的主要花粉过敏原成分。结果发现，Phl p 4 是花粉过敏性哮喘患者的主要过敏原成分，而 Amb a 1 则是花粉过敏性鼻炎患者的主要过敏原成分。

超370万人大规模队列研究：感染新冠之后，即使是轻症，过敏风险也大大增加，尤其是哮喘和过敏性鼻炎

Nature子刊：在感染新冠病毒后的30天中，罹患过敏性疾病的风险显著增加了20%，尤其是哮喘和过敏性鼻炎。

2009 NICE儿童慢性哮喘管理指南 - 2009更新

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2009-12-01

2009 SACAWG儿童慢性哮喘管理指南（更新版）

南非儿童哮喘工作组(SACAWG,South African Childhood Asthma Working Group) · 2009-12-20

2010 GINA 全球哮喘处理和预防策略

全球哮喘防治创议(GINA,Global INitiative for Asthma) · 2010-01-01

2010CTS 年共识，总结六岁及以上的儿童和成人哮喘的管理指南

加拿大胸科学会(CTS,Canadian Thoracic Society) · 2010-01-01

2010BC 哮喘-诊断和管理

英国哥伦比亚临床实践指南中心(BC,Clinical Practice Guidelines and Protocols in British Columbia) · 2010-01-01

2010NAC在儿童哮喘管理的白三烯受体拮抗剂

澳大利亚国家哮喘委员会(NAC,National Asthma Council (Australia)) · 2010-01-01